These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 18790451)
1. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia. Rowe JM Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451 [TBL] [Abstract][Full Text] [Related]
2. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease. Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease. Valcárcel D; Martino R; Piñana JL; Sierra J Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S35-7. PubMed ID: 19561412 [TBL] [Abstract][Full Text] [Related]
4. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease. Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919 [TBL] [Abstract][Full Text] [Related]
5. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
6. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355 [TBL] [Abstract][Full Text] [Related]
7. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia. Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407 [TBL] [Abstract][Full Text] [Related]
8. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease. Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G Bone Marrow Transplant; 1991; 7 Suppl 2():9-10. PubMed ID: 1878737 [No Abstract] [Full Text] [Related]
9. Chronic graft-versus-host disease following allogeneic peripheral blood and bone marrow stem cell transplants: a single center experience. Takami A; Ishiyama K; Asakura H; Shiobara S; Nakao S Haematologica; 2002 Jun; 87(6):664-6. PubMed ID: 12031928 [No Abstract] [Full Text] [Related]
10. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients. Pérez A; González-Vicent M; Ramirez M; Sevilla J; Madero L; Díaz MA Br J Haematol; 2008 Feb; 140(3):340-3. PubMed ID: 18053071 [TBL] [Abstract][Full Text] [Related]
11. The graft-versus-leukaemia effect after allogeneic bone-marrow transplantation: assessment through competing risks approaches. Katsahian S; Porcher R; Mary JY; Chevret S Stat Med; 2004 Dec; 23(24):3851-63. PubMed ID: 15580602 [TBL] [Abstract][Full Text] [Related]
12. Induction of late graft-versus-host disease in a patient post-allogeneic stem cell transplantation by progesterone in conjunction with donor lymphocyte infusion. Gesundheit B; Shapira MY; Maly A; Samuel S; Budowski E; Or R Leuk Res; 2008 Mar; 32(3):501-3. PubMed ID: 17727947 [TBL] [Abstract][Full Text] [Related]
13. The role of immunotherapy in bone marrow transplantation for acute myeloid leukemia. Prentice HG; Macdonald ID; Hamon MD Prog Clin Biol Res; 1994; 389():239-43. PubMed ID: 7700907 [No Abstract] [Full Text] [Related]
14. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Loren AW; Porter DL Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156 [TBL] [Abstract][Full Text] [Related]
15. Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic stem cell transplantation. Montagna D; Maccario R; Locatelli F Int J Immunogenet; 2008 Aug; 35(4-5):389-93. PubMed ID: 18976444 [TBL] [Abstract][Full Text] [Related]
16. Peptide vaccines for patients with acute myeloid leukemia. Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762 [TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukemia in chronic lymphocytic leukemia. Ben-Bassat I; Raanani P; Gale RP Bone Marrow Transplant; 2007 Apr; 39(8):441-6. PubMed ID: 17322931 [TBL] [Abstract][Full Text] [Related]
18. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML. Craddock CF Bone Marrow Transplant; 2008 Mar; 41(5):415-23. PubMed ID: 18209726 [TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. Lekakis L; de Lima M Expert Rev Anticancer Ther; 2008 May; 8(5):785-98. PubMed ID: 18471050 [TBL] [Abstract][Full Text] [Related]